Concepedia

Norbert Bräu

NB

Statistics

Publications

57

Citations

7.8K

H-Index

31

Active since

1992

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

James J. Peters VA Medical Center

Johns Hopkins University

Veterans Health Administration

University of California San Diego

Norbert Bräu is an author at Icahn School of Medicine at Mount Sinai specializing in viral hepatitis, antiviral therapy, and pharmacotherapy.

Publications per year

1992–2022

57

Publications

57

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

, , +17

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · New England Journal of Medicine · 2021 · 1.1K citations · Full text

, , +13

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

, , +17

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Susanna Naggie, Curtis Cooper, Michael S. Saag et al. · New England Journal of Medicine · 2015 · 467 citations · Full text

, , +17

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

Edward Gane, Eric Lawitz, David Pugatch et al. · New England Journal of Medicine · 2017 · 398 citations · Full text

, , +15

1–5 of 57